You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

List of Excipients in API bortezomib


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing bortezomib

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Hospira Inc BORTEZOMIB bortezomib 0409-1703 MANNITOL
Takeda Pharmaceuticals America Inc VELCADE bortezomib 63020-049 MANNITOL
Fresenius Kabi USA LLC BORTEZOMIB bortezomib 63323-721 BORIC ACID
Fresenius Kabi USA LLC BORTEZOMIB bortezomib 63323-721 GLYCINE
MAIA Pharmaceuticals Inc BORTEZOMIB bortezomib 70511-161 DIMETHYL SULFOXIDE
MAIA Pharmaceuticals Inc BORTEZOMIB bortezomib 70511-161 HYDROCHLORIC ACID
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing bortezomib

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc bortezomib 0143-9098 MANNITOL
Hospira Inc bortezomib 0409-1700 MANNITOL
Baxter Healthcare Corporation bortezomib 10019-991 MANNITOL
Accord Healthcare Inc bortezomib 16729-241 MANNITOL
Sagent Pharmaceuticals bortezomib 25021-244 MANNITOL
Camber Pharmaceuticals Inc bortezomib 31722-303 MANNITOL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for bortezomib

Excipient focus: BORIC ACID

Excipient focus: DIMETHYL SULFOXIDE

Excipient focus: GLYCINE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: MANNITOL

Excipient focus: SODIUM ACETATE

Excipient focus: SODIUM HYDROXIDE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group